Brief: Synact Pharma Q2 pre-tax loss at SEK 5.2 million
31/08/2017 13:45
Aug 31 (Reuters) - SYNACT PHARMA AB SYNACT.ST :
* Q2 PRE-TAX LOSS SEK 5.2 MILLION VERSUS SEK 5.6 MILLION YEAR AGO
Source text for Eikon: ID:nWkr2K5RyX
Further company coverage: SYNACT.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026